I-Mab - ADR

NASDAQ:IMAB

2.13

+0.08 (+3.90%)

7:19:17 PM EDT: $2.10 -0.03 (-1.41%)

I-Mab - ADR Stock, NASDAQ:IMAB

2440 Research Boulevard, Suite 400, Rockville, Maryland 20850

United States of America

Phone: +1.240.745.6330

Number of Employees: 220

http://www.i-mabbiopharma.com

Description

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.